"Mercy Regional Cancer Center is a cancer center that offers many services, including cancer care, chemotherapy, and imaging. Visit Mercy Regional Cancer Center located at 2175 Rosaline Ave, Redding, CA. This Redding cancer center is one of the best in California. As part of the Dignity Health network, Mercy Regional Cancer Center is dedicated to delivering high quality, compassionate care and access to Redding and nearby communities."

During the past decade, Mercy Regional Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Regional Cancer Center" are "Breast Cancer" (3 trials), "Breast Carcinoma" (2 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Mercy Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Mercy Regional Cancer Center" are "Other" (10 trials), "Drug" (9 trials), "Biological" (5 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Carboplatin" (3 trials), "Computed Tomography" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Regional Cancer Center" are 7 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Regional Cancer Center". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mercy Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".